The Effect of Mannitol Volume with Changes in Osmolarity in Traumatic Brain Injury
NCT06846307 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2025-03-03
Summary
This observational study is designed to research the effect of mannitol volume administration with changes in osmolarity in patients with traumatic brain injury to guide the safe use of mannitol in these patients.
Conditions
- Anesthesia
- Traumatic Brain Injury
Interventions
- DRUG
-
Mannitol
mannitol administration across all three dosages (3x125 cc, 2x250 cc, 3x250 cc) given as an IV drip for 15-20 minutes
Sponsors & Collaborators
-
Universitas Diponegoro
lead OTHER
Principal Investigators
-
Aria P Hayanto, Sp.An-TI · Universitas Diponegoro
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2024-01-29
- Completion
- 2024-01-31
Countries
- Indonesia
Study Locations
More Related Trials
-
Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis Values
NCT01028339 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating the Effect of Tranexamic Acid on the Clinical Outcomes in Patients With Traumatic Brain Injury
NCT06330935 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cerebral Oxymetry in Traumatic Brain Injury
NCT01940861 ·Status: UNKNOWN
-
Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral Monitoring
NCT00795587 ·Status: TERMINATED ·Phase: PHASE4
-
Multimodal Monitoring Study in Neuro Critical Care
NCT06900101 ·Status: RECRUITING
-
Comparison of Two Doses of Mannitol on Brain Relaxation During Supratentorial Craniotomy
NCT01048684 ·Status: COMPLETED ·Phase: NA
-
Intracranial Pressure (ICP) Monitoring Following Traumatic Brain Injury (TBI)
NCT04428970 ·Status: COMPLETED
-
Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury
NCT04212754 ·Status: UNKNOWN
-
Dexmedetomidine on Brain Injury Patients
NCT06661980 ·Status: COMPLETED ·Phase: NA
-
Mgso4 as Neuroprotective in Post Traumatic Brain Injury
NCT04646876 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
NCT06052787 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation Patterns of Brain Temperature-Pressure in Acute Brain Injury
NCT06101537 ·Status: COMPLETED
-
Point of Care Optic Nerve Sheath Ultrasound to Assess Intracranial Pressure
NCT04686344 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage
NCT05858060 ·Status: RECRUITING
-
Prioritization of Cerebral Deoxygenation in Severe Traumatic Brain Injury and Mortality Benefit.
NCT06306950 ·Status: COMPLETED ·Phase: NA
-
Early Induced Hypernatremia for the Prevention and Management of Brain Edema
NCT02798601 ·Status: WITHDRAWN ·Phase: NA
-
Transcranial Doppler Measurement and Prognosis in Moderate Head Injury
NCT00353444 ·Status: SUSPENDED
-
Sodium-Lactate and Traumatic Brain Injury
NCT00319345 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Coagulation Activation by Hyperosmolar Agents in Intracranial Hypertension
NCT03409237 ·Status: WITHDRAWN
-
The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
NCT05095857 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Cerebral Oxygenation and Hemodynamics in Patients With Cerebral Venous Thrombosis
NCT03033966 ·Status: COMPLETED
-
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
NCT04242602 ·Status: COMPLETED
-
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury
NCT06480838 ·Status: RECRUITING
-
Ocular Ultrasonography as a Tool for Monitoring the Management of Traumatic Brain Injury
NCT03795896 ·Status: UNKNOWN ·Phase: NA
-
Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial Pressure
NCT00447018 ·Status: COMPLETED ·Phase: PHASE4